Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
about
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.Use of drugs for ADHD among adults-a multinational study among 15.8 million adults in the Nordic countries.The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research.An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.
P2860
Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@ast
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@en
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@nl
type
label
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@ast
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@en
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@nl
prefLabel
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@ast
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@en
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@nl
P2093
P2860
P1476
Attention-deficit/hyperactivit ...... ong-term cardiovascular risks?
@en
P2093
Mark E Alexander
Paul G Hammerness
Ronke Babalola
P2860
P304
P356
10.1517/14740338.2015.1011620
P407
P577
2015-02-03T00:00:00Z